Boosting Osimertinib Blood Brain Barrier Penetration

Clinical trial NCT07485452 · RECRUITING

Trial details

NCT number: NCT07485452
Sponsor: Maastricht University Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2026-06-01
Primary completion: 2027-06-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.